格隆汇10月30日｜葛兰素史克公布第三季度业绩，营收80.12亿英镑，同比下降2%，低于分析师预期的81亿英镑；扣除部分项目后的每股收益为49.7便士，高于分析师预测的44便士。期内疫苗销售额下降18%至26.5亿英镑。该公司重申2024年调整后每股收益将增长10至12%，核心营业利润将增长11至13%，销售额将增长7至9%。

海量资讯、精准解读，尽在新浪财经APP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.